LAUREN PERKINS: Open Payments
NPI 1760882104 · NORTHPORT, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,197 in 56 payments from 22 companies in 2025. Trend: 2023 $4,879 · 2024 $5,069 · 2025 $1,197
Food & beverage: $1,197
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 5 | $159 |
| ABBVIE INC. | 9 | $158 |
| Novartis Pharmaceuticals Corporation | 5 | $81 |
| Neurocrine BioSciences, Inc. | 4 | $80 |
| PFIZER INC. | 4 | $78 |
| Eisai Inc. | 2 | $63 |
| ARGENX US, INC. | 3 | $61 |
| SK Life Science, Inc. | 2 | $61 |
| Otsuka America Pharmaceutical, Inc. | 3 | $55 |
| Lilly USA, LLC | 3 | $55 |
Products named: Rystiggo, KESIMPTA, INGREZZA, Briviact, Leqembi, REXULTI, NURTEC ODT, VRAYLAR.
Industry payments across AL — which companies pay providers there.
